AMES, Iowa, Nov. 19, 2007 (PRIME NEWSWIRE) -- BioForce Nanosciences Holdings Inc. (OTC BB:BFNH.OB - News) today announced the receipt of $500,000 in proceeds from the exercise of the Series C warrants issued in its August 2007 financing transaction with an institutional investor. The Series C warrants entitled the investor to purchase 1,000,000 shares of BioForce's common stock at a price of $0.50 per share. These warrant exercise proceeds are in addition to the $500,000 of initial investment proceeds received in August.
